Our primary ambition is to find innovative projects and products that will advance neuroscience and develop novel and innovative treatments for patients. By combining our internal R&D capabilities with external alliances, we significantly broaden the opportunities to achieve our end goal. These include:
- Discovery technology platforms
- Enabling technologies, such as biomarkers and imaging
- Digital platforms, such as wearables
- Discovery projects
- Pre-clinical projects
- Early and mid-stage developments projects
- Regional and global commercialized products
Successful partnerships, from early-stage science to commercialization, have been one of the main drivers in establishing Lundbeck’s current position in brain science. We actively seek access to external innovation, particularly where we see best-in-class opportunities to develop transformative medicines, and where we can leverage our own global drug development and commercial expertise to bring new medicines to patients.
Our partnerships are equally valued, whether small or large, which allows us to fine-tune each partnership according to specific needs and circumstances. Across our therapeutic, technological and research areas, we seek: